Journal of Translational Medicine · 2005 · 12 citations · 18 references
MedicineHematologyObstetricsAutoimmunityClinical ImmunologyHemostasisAntiphospholipid SyndromeCoagulation AbnormalitiesCoagulation DisordersCoagulation Factor DeficienciesHemostatic DisordersThrombosisActivated Partial Thromboplastin Time ProlongationAnticardiolipin AntibodiesAntiphospholipid Syndrome-associated Pregnancy LossDifferential Diagnosis CriteriaFactor Xii ActivationRecurrent Pregnancy Loss ManagementRecurrent Pregnancy Loss PathologyUnexplained Recurrent Pregnancy Loss
BACKGROUND: Antiphospholipid syndrome (APS) has been often associated to RPL since 1980 and some reports in the Literature rarely described antibodies to factor XII in patients with APS. CASE HISTORY: We report the case history of 34-year-old caucasian women with recurrent fetal loss and persistent prolonged activated partial thromboplastin time. Haemostatic tests revealed persistent light decrease of clotting factor XII with normal values of IgG and IgM anticardiolipin antibodies and transient positivity for lupus anticoagulant (LA). Few reports in the Literature described antibodies to factor XII in patient with antiphospholipid syndrome (APS) and transient LA. So, once other causes of RPL were excluded, the patient was diagnosed an unusual form of APS associated to antibodies to factor XII, reduced factor XII plasma levels, transient LA and prolonged activated partial thromboplastin time. DISCUSSION: We suggest to consider also antibodies directed to clotting factors (e.g. factor XII in our case) as second step of thrombophilia screening in RPL, in particular if a persistent prolonged aPTT is present without an apparent cause.
18
Mutations in Coagulation Factors in Women with Unexplained Late Fetal Loss
Ida Martinelli, Emanuela Taioli, Irene Cetin et al. · New England Journal of Medicine · 2000 · 313 citations
Luis S. Noble, William H. Kutteh, Nanette Lashey et al. · Fertility and Sterility · 2005 · 234 citations
Medicine, Immunology, Obstetrics +17